Results 301 to 310 of about 4,627,366 (384)

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Serum Soluble ST2 and IL-33 Levels in Finnish Patients With Juvenile Idiopathic Arthritis. [PDF]

APMIS
Teräsjärvi J, Möttönen M, Rahikkala H, Kvist S, Anabe D, Mertsola J, He Q.   +6 more
europepmc   +1 more source

NRP1 downregulation correlates with enhanced ILC2 responses during IL‐33 challenge [PDF]

Ying Wang, Gaoyu Liu, Jianye Wang, Pan Zhou, Lijuan Zhang, Qiang Liu, Jie Zhou   +6 more
openalex   +1 more source

Murine asthma model focusing on IL-33

Folia Pharmacologica Japonica, 2017
Takeshi, Nabe, Nobuaki, Mizutani, Masaya, Matsuda   +2 more
openaire   +3 more sources

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

CAF derived IL-33 mediated EMT to promote the metastasis of LSCC cells. [PDF]

Eur J Med Res
Yang L, Zhou J, Chen S, Wang Y, Huang S.
europepmc   +1 more source

DNA methylation and expression of MAPRE3 affect overall survival of early‐stage non‐small cell lung cancer patients

Molecular Oncology, EarlyView.
Both cg12821679MAPRE3 methylation and MAPRE3 expression are significantly associated with overall survival (OS) of non‐small cell lung cancer. Meanwhile, MAPRE3 expression significantly modified the effect of smoking cessation on OS. Smoking cessation benefits OS merely for patients with high MAPRE3 expression.
Chao Chen, Jiancheng Cheng, Ruili Hou, Xiaoyuan Zheng, Li Su, Maria Moksnes Bjaanæs, Anna Karlsson, Maria Planck, Johan Staaf, Åslaug Helland, Manel Esteller, David C. Christiani, Feng Chen, Xiaofei Cao, Ruyang Zhang   +14 more
wiley   +1 more source

IL-33-induced neuroimmune regulation in depression: A narrative review from molecular mechanisms to therapeutic potential. [PDF]

Medicine (Baltimore)
Wang G, Zhang X, Duan G, Yuan S.
europepmc   +1 more source

Defining the Roles of IL-33, Thymic Stromal Lymphopoietin, and IL-25 in Human Asthma

, 2014
Derek E. Byers
openalex   +2 more sources